Hills Bank & Trust’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.73M | Buy |
3,941
+522
| +15% | +$533K | 0.2% | 65 |
|
|
2026
Q1 | $3.14M | Buy |
3,419
+242
| +8% | +$245K | 0.15% | 71 |
|
|
2025
Q4 | $3.41M | Buy |
3,177
+196
| +7% | +$187K | 0.2% | 67 |
|
|
2025
Q3 | $2.27M | Sell |
2,981
-148
| -5% | -$110K | 0.13% | 94 |
|
|
2025
Q2 | $2.44M | Sell |
3,129
-65
| -2% | -$50.5K | 0.15% | 87 |
|
|
2025
Q1 | $2.64M | Sell |
3,194
-220
| -6% | -$183K | 0.19% | 81 |
|
|
2024
Q4 | $2.64M | Sell |
3,414
-331
| -9% | -$274K | 0.2% | 77 |
|
|
2024
Q3 | $3.32M | Buy |
3,745
+360
| +11% | +$324K | 0.25% | 70 |
|
|
2024
Q2 | $3.06M | Buy |
3,385
+41
| +1% | +$32.8K | 0.25% | 67 |
|
|
2024
Q1 | $2.6M | Buy |
3,344
+199
| +6% | +$142K | 0.22% | 75 |
|
|
2023
Q4 | $1.83M | Sell |
3,145
-229
| -7% | -$134K | 0.18% | 89 |
|
|
2023
Q3 | $1.81M | Sell |
3,374
-911
| -21% | -$469K | 0.21% | 82 |
|
|
2023
Q2 | $2.01M | Sell |
4,285
-348
| -8% | -$146K | 0.26% | 68 |
|
|
2023
Q1 | $1.59M | Sell |
4,633
-587
| -11% | -$198K | 0.22% | 77 |
|
|
2022
Q4 | $1.91M | Sell |
5,220
-707
| -12% | -$251K | 0.28% | 64 |
|
|
2022
Q3 | $1.92M | Sell |
5,927
-1,147
| -16% | -$363K | 0.28% | 61 |
|
|
2022
Q2 | $2.29M | Sell |
7,074
-783
| -10% | -$235K | 0.37% | 53 |
|
|
2022
Q1 | $2.25M | Buy |
7,857
+30
| +0.4% | +$7.72K | 0.32% | 61 |
|
|
2021
Q4 | $2.16M | Buy |
7,827
+236
| +3% | +$59.8K | 0.3% | 67 |
|
|
2021
Q3 | $1.75M | Buy |
7,591
+598
| +9% | +$148K | 0.27% | 71 |
|
|
2021
Q2 | $1.6M | Buy |
6,993
+32
| +0.5% | +$6.43K | 0.24% | 78 |
|
|
2021
Q1 | $1.3M | Buy |
6,961
+183
| +3% | +$35.8K | 0.21% | 86 |
|
|
2020
Q4 | $1.14M | Buy |
6,778
+459
| +7% | +$68.5K | 0.2% | 91 |
|
|
2020
Q3 | $935K | Buy |
6,319
+1,330
| +27% | +$206K | 0.18% | 94 |
|
|
2020
Q2 | $819K | Buy |
4,989
+340
| +7% | +$52.2K | 0.17% | 96 |
|
|
2020
Q1 | $645K | Buy |
4,649
+877
| +23% | +$120K | 0.19% | 83 |
|
|
2019
Q4 | $496K | Buy |
3,772
+595
| +19% | +$69K | 0.12% | 106 |
|
|
2019
Q3 | $355K | Buy |
3,177
+1,194
| +60% | +$133K | 0.09% | 119 |
|
|
2019
Q2 | $220K | Buy |
1,983
+157
| +9% | +$18.5K | 0.06% | 151 |
|
|
2019
Q1 | $237K | Hold |
1,826
| – | – | 0.06% | 146 |
|
|
2018
Q4 | $212K | Buy |
+1,826
| New | +$204K | 0.07% | 135 |
|
Other funds holding LLY
Hills Bank & Trust's LLY Position: Q2 2026 in Review
Hills Bank & Trust increased its Eli Lilly (LLY) stake by 15% in Q2 2026, buying an estimated $533K and bringing the position to 3,941 shares worth $4.73M. The position accounts for 0.2% of the portfolio, ranked #65.
Hills Bank & Trust first reported a position in LLY in Q4 2018 and has held it in 31 quarters since. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Hills Bank & Trust held 3,941 shares of Eli Lilly worth $4.73M as of Q2 2026.
- Hills Bank & Trust bought 522 Eli Lilly shares in Q2 2026, an estimated $533K.
- Eli Lilly made up 0.2% of Hills Bank & Trust's portfolio in Q2 2026, its #65 holding.
- Hills Bank & Trust first reported a position in Eli Lilly in Q4 2018 and has held it in 31 quarters since.
- 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Hills Bank & Trust's 13F filing for Q2 2026, filed 10 Aug 2026.